US Patent Issued to SENGENICS SDN BHD, National University of Singapore on April 14 for "Detection of biomarkers for non-small cell lung cancer" (Singaporean, Malaysian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,601,741, issued on April 14, was assigned to SENGENICS SDN BHD (Kuala Lumpur, Malaysia) and National University of Singapore (Singapore).

"Detection of biomarkers for non-small cell lung cancer" was invented by Jonathan Michael Blackburn (Singapore), Arif Anwar (Kuala Lumpur, Malaysia), Boon Cher Goh (Singapore), Lingzhi Wang (Singapore), Sok Hwee Esther Cheow (Singapore), Ross Andrew Soo (Singapore) and Win Lwin Thuya (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for diagnosing Non-Small Cell Lung Cancer (NSCLC) from a sample extracted from a subject by testing the sample for the presence of biomarkers, the biomarkers being autoan...